August 16, 2021
As cited by the research report titled ‘Neuroendoscopy Market Size By Product (Rigid Neuroendoscopes {Rigid Fiberscopes, Rigid Videoscopes}, Flexible Neuroendoscopes), By Application, By Usability (Reusable Neuroendoscopes, Disposable Neuroendoscopes), By Patient (Adult, Pediatric), By End-use (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers) Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report, global neuroendoscopy market valuation is projected to surpass USD 250 million by 2025.
Rising geriatric populace and advantages associated with neuroendoscopic devices are primarily driving the global neuroendoscopy market growth. Technological advancements & innovations in minimally invasive procedures are also augmenting the market outlook.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2419664/
Moreover, rising number of cases of brain tumor and central nervous system as well as cancer are enhancing the adoption of neuroendoscopy surgical procedures, thus positively swaying the market dynamics.
Based on product range, the worldwide neuroendoscopy market is segmented into rigid and flexible neuroendoscopes. Among these, rigid neuroendoscopes segment accounted for USD 120 million valuation in 2018 and is anticipated to grow significantly over the forecast timeline owing to their extensive use in intraventricular neuroendoscopy and endoscopic procedures to investigate the internal body organs using a tubular telescope.
Speaking of the application ambit, the marketplace is divided into transnasal neuroendoscopy, transcranial neuroendoscopy, and intraventricular neuroendoscopy. As cited in the report, transnasal neuroendoscopy segment is likely to seize 25.1% market share over the analysis period on account of growing applications of transnasal neuroendoscopy surgical procedures.
Considering usability, the industry space is categorized into reusable neuroendoscopes, and disposable neuroendoscopes. Among these, disposable neuroendoscopes segment is poised to expand at 5.5% CAGR over the forecast timeframe as they are sterile and possess reduced risk of patient infection.
By patient type, the market is classified into adult and pediatric. Among these, global neuroendoscopy market size from pediatric segment amassed around USD 25 million in 2018 and is expected to showcase lucrative growth trends through the forecast timeline owing to prevalence of various types of tumors among children.
Moving on to the end user spectrum, the business space is fragmented into hospitals, diagnostic centers, and ambulatory surgical centers. As cited in the report, ambulatory surgical centers segment held 20% market share in 2018 and is anticipated to witness significant growth over the analysis period. This can be attributed to the various benefits associated with the technology, availability of skilled healthcare professionals, and increasing number of neuro surgeries.
Considering the regional framework, Asia Pacific neuroendoscopy market share accounted for around USD 30 million in 2018 and is reckoned to showcase steady growth over the forecast duration, owing to growing awareness among individuals regarding the neuroendoscopy procedures to efficiently diagnose patient health. Moreover, rising healthcare expenditure in developing countries is promoting regional growth.
Prominent players influencing the worldwide neuroendoscopy industry dynamics are Machida Endoscope Co. Ltd., Hangzhou Hawk Optical Electronic Instruments Co Ltd., Karl Storz SE & Co KG, Clarus Medical LLC, adeor Medical AG, Tonglu Wanhe Medical Instrument Co. Ltd., B. Braun Melsungen AG, Schindler Endoskopie Technologie GmbH, and Ackermann Instrumente GmbH.